Why do Americans choose healthcare options that cost more but may not even do more or be in the best interest of their own health? Dr. Bob Nease, chief scientist at Express Scripts, tells host Bruce Japsen about what appears to be a troubling phenomena researchers are calling the behavioral economics of healthcare.
Paying More For Worse Outcomes: Behavioral Economics & Healthcare

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Why do Americans choose healthcare options that cost more but may not even do more or be in the best interest of their own health? Dr. Bob Nease, chief scientist at Express Scripts, tells host Bruce Japsen about what appears to be a troubling phenomena researchers are calling the behavioral economics of healthcare.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Biomarkers of the Storm: Decoding IRI’s Signature
HF Management for Patients with Comorbid Conditions
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Personalizing Care Within the RCC Treatment Paradigm
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?